Manoj Doss, DO

Dr. Manoj Doss is a board-certified physician, addiction medicine specialist, and founder of the Institute for Integrative Therapies (IIT), Minnesota’s first psychedelic medicine clinic. He is nationally recognized for pioneering an evidence-based, medically grounded approach to psychedelic-assisted therapies and for treating more patients using a facilitation model than any physician in the state.

With a multidisciplinary background spanning medicine, public health, spatial analytics, and clinical research, Dr. Doss integrates rigorous scientific practice with compassionate, person-centered care. His clinical expertise includes psychedelic medicine and addiction medicine.

As Founder & CEO of IIT, Dr. Doss built one of the country’s first full-stack psychedelic medicine centers, offering ketamine-based programs, integration therapy, and advanced mental-health services. He also created a therapist apprenticeship program that has trained more than 50 clinicians in psychedelic-assisted therapy, expanding access to safe and ethical care.

Dr. Doss leads IIT’s rapidly expanding research division and is deeply involved in shaping the future of psychedelic clinical trials in Minnesota. He serves as a Principal Investigator and Sub-Investigator on multiple groundbreaking studies, including Phase 3 psilocybin trials for treatment-resistant depression, next-generation DMT and psilocin programs, and emerging psychedelic treatments for addiction. His responsibilities encompass medical oversight, safety monitoring, protocol adherence, and rater functions—ensuring the highest standards of Good Clinical Practice (GCP).

Beyond direct study execution, Dr. Doss is actively developing strategic relationships with sponsors and CROs, positioning IIT as a preferred site for ongoing and future psychedelic research. His vision is to build Minnesota’s premier psychedelic research infrastructure, supporting large-scale, multisite clinical trials and fostering innovation in psychedelic science.

He also created a clinical research internship program for the University of Wisconsin–Madison’s Psychoactive Pharmaceutical Investigation (PPI) Master’s Program, providing graduate students with hands-on training, mentorship, and an immersive pathway into psychedelic research careers.

Dr. Doss holds degrees from Virginia Tech, the University of Delaware, the University of Pennsylvania, and the Edward Via College of Osteopathic Medicine. He is board-certified in Addiction Medicine.

Through his clinical work, research leadership, and public education efforts, Dr. Doss is committed to advancing psychedelic medicine and expanding access to innovative treatments for those who need them most.